Category Archive

Information

Health Canada updates safety information for Trileptal (oxcarbazepine)

August 5, 2011

Health Canada Endorsed Important Safety Information on TRILEPTAL (oxcarbazepine): Association of TRILEPTAL (oxcarbazepine) with life-threatening dermatological reactions and multi-organ hypersensitivity In April 2005, Novartis Pharmaceuticals Canada Inc. distributed a letter to Canadian healthcare professionals concerning the updated consumer information for Trileptal tablets and oral suspension. Trileptal is used as a monotherapy or adjunctive therapy to…

Health Canada updates safety information on Lamictal (lamotrigine)

August 5, 2011

Health Canada Endorsed Important Safety Information on LAMICTAL (lamotrigine): Important Safety Information Concerning Interactions of the Anti-epileptic Drug Lamictal In September 2004, GlaxoSmithKline Inc. distributed a letter to Canadian healthcare professionals concerning the safety of the anti-epileptic drug, Lamictal. Women who combined Lamictal with their birth control pills have reported the following: seizures unexpected pregnancies…

U.S. Patients Seeking Medications from Canada

August 5, 2011

U.S. Federal Policy As a general matter, it is illegal to import an unapproved drug into the U.S. However, under Food and Drug Administration’s (FDA) personal importation policy, FDA has authorized its inspectors to use their enforcement discretion to allow U.S. residents to import certain products under certain limited conditions. Under this policy, FDA may…

Phenobarbital

August 5, 2011

Phenobarbital is available in Canada by prescription only. Known as Phenobarbital Phenobarb Luminal Uses Phenobarbital (the longest-established anticonvulsant medication) controls epileptic seizures, depresses the central nervous system and is used occasionally as a sedative. It is generally used to control tonic-clonic, and simple partial seizures. There is disagreement about its efficacy for complex partial seizures.…